In 2001, when Congress was attempting to ban all forms of cloning, Geron CEO Thomas Okarma spoke before Congress to preserve cloning for therapeutic purposes.
•
The company's Scientific and Clinical Advisory Board has included James Thomson, Leonard Hayflick, Carol Greider, and others.
•
The company is in the early stages of developing a telomerase based treatment for HIV called TAT0002, which is the saponin cycloastragenol in Chinese herb Astragalus propinquus.
Canadian Broadcasting Corporation | Australian Broadcasting Corporation | Oracle Corporation | International Finance Corporation | Chevron Corporation | Digital Equipment Corporation | News Corporation | Lockheed Corporation | corporation | Hearst Corporation | Scholastic Corporation | Northrop Corporation | Munhwa Broadcasting Corporation | Gibson Guitar Corporation | CBS Corporation | Fender Musical Instruments Corporation | ITT Corporation | Sharp Corporation | RAND Corporation | NCR Corporation | Federal Deposit Insurance Corporation | Sperry Corporation | Singer Corporation | Case Corporation | Science Applications International Corporation | Polaroid Corporation | Multinational corporation | Burroughs Corporation | Bendix Corporation | Olympus Corporation |
In the mid-1990s, Greider was recruited by Michael D. West, founder of biotechnology company Geron (now CEO of BioTime) to join the company's Scientific Advisory Board.
From 1995 to 1998 Michael D. West, PhD, organized and managed the research between Geron Corporation and its academic collaborators James Thomson at the University of Wisconsin-Madison and John Gearhart of Johns Hopkins University that led to the first isolation of human embryonic stem and human embryonic germ cells.